Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis
Wenxiang Hong,
No information about this author
Hongbo Ma,
No information about this author
Zhaoxu Yang
No information about this author
et al.
Acta Pharmaceutica Sinica B,
Journal Year:
2025,
Volume and Issue:
15(3), P. 1626 - 1642
Published: Feb. 11, 2025
Dendritic
cells
(DCs)
serve
as
the
primary
antigen-presenting
in
autoimmune
diseases,
like
rheumatoid
arthritis
(RA),
and
exhibit
distinct
signaling
profiles
due
to
antigenic
diversity.
Type
II
collagen
(CII)
has
been
recognized
an
RA-specific
antigen;
however,
little
is
known
about
CII-stimulated
DCs,
limiting
development
of
therapeutic
interventions.
In
this
study,
we
show
that
DCs
display
a
preferential
gene
expression
profile
associated
with
migration,
offering
new
perspective
for
targeting
DC
migration
RA
treatment.
Then,
saikosaponin
D
(SSD)
was
identified
compound
capable
blocking
CII-induced
effectively
ameliorating
arthritis.
Optineurin
(OPTN)
further
revealed
potential
SSD
target,
Optn
deletion
impairing
CII-pulsed
without
affecting
maturation.
Function
analyses
uncover
OPTN
prevents
proteasomal
transport
ubiquitin-dependent
degradation
C-C
chemokine
receptor
7
(CCR7),
pivotal
migration.
Optn-deficient
reduced
CCR7
expression,
leading
slower
CII-surrounded
environment,
thus
alleviating
progression.
Our
findings
underscore
significance
antigen-specific
activation
suggest
crucial
regulator
CII-specific
emerges
promising
drug
target
RA,
potentially
significant
value
management
RA.
Language: Английский
On the Exploitation of Lignin Slow Pyrolysis Products
Energies,
Journal Year:
2025,
Volume and Issue:
18(4), P. 943 - 943
Published: Feb. 16, 2025
The
potential
of
technical
lignins
as
secondary
raw
materials
is
discussed.
characteristics
lignin
pyrolysis,
with
particular
emphasis
on
slow
pyrolysis
technologies,
are
briefly
summarized.
process,
which
can
be
self-sustained
by
burning
the
coproduced
gas,
primarily
produce
high-quality
biochar
in
significant
amounts,
to
used
a
fuel,
reductant
metallurgy,
and
an
adsorbent
catalyst
component.
Together,
amounts
bio-oil
produced,
rich
guaiacols,
commercial
expensive
chemicals
produced
today
via
petrochemical
routes
pharmacology,
food
chemistry,
polymer
etc.
Such
compounds,
or
itself,
also
converted
hydrodeoxygenation
into
biofuels.
A
possible
simplified
flowsheet
for
process
frame
ligneocellulosics-based
biorefinery
proposed.
Language: Английский
Gastrodin promotes CNS myelinogenesis and alleviates demyelinating injury by activating the PI3K/AKT/mTOR signaling
Xiaoyu Shi,
No information about this author
Yixi He,
No information about this author
Maofa Ge
No information about this author
et al.
Acta Pharmacologica Sinica,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 26, 2025
Abstract
Demyelination
is
a
common
feature
of
numerous
neurological
disorders
including
multiple
sclerosis
and
leukodystrophies.
Although
myelin
can
be
regenerated
spontaneously
following
injury,
this
process
often
inadequate,
potentially
resulting
in
neurodegeneration
exacerbating
dysfunction.
Several
drugs
aimed
at
promoting
the
differentiation
oligodendrocyte
precursor
cells
(OPCs)
have
yielded
unsatisfactory
clinical
effects.
A
recent
study
has
shifted
strategy
pro-OPC
towards
enhancing
myelinogenesis.
In
we
identified
pro-myelinating
drug
using
zebrafish
model.
Five
traditional
Chinese
medicine
monomers
gastrodin,
paeoniflorin,
puerarin,
salidroside
scutellarin
were
assessed
by
bath-application
Tg
(MBP:eGFP-CAAX)
transgenic
line
1–5
dpf.
Among
5
monomers,
only
gastrodin
exhibited
significant
pro-myelination
activity.
We
showed
that
(10
µM)
enhanced
sheath
formation
(OL)
maturation
without
affecting
number
OLs.
Gastrodin
markedly
increased
phosphorylation
levels
PI3K,
AKT,
mTOR
primary
cultured
OLs
via
direct
interaction
with
PI3K.
Co-treatment
PI3K
inhibitor
LY294002
(5
mitigated
gastrodin-induced
OL
maturation.
Furthermore,
injection
(100
mg·kg
−1
·d
,
i.p.)
effectively
facilitated
remyelination
lysophosphatidylcholine-induced
demyelinating
mouse
model
alleviated
demyelination
experimental
autoimmune
encephalomyelitis
mice.
These
results
identify
as
promising
therapeutic
agent
for
diseases
highlight
potential
screening
pro-myelinogenic
pharmacotherapy.
Language: Английский
THE ROLE OF TRADITIONAL CHINESE MEDICINE IN ADDRESSING THE CHALLENGES OF CLOSTRIDIAL GAS GANGRENE: A MULTIFACETED APPROACH
Pharmacological Research - Natural Products,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100198 - 100198
Published: March 1, 2025
Language: Английский
Steroidal saponins: a treasure trove of natural resources that require urgent development
Phytochemistry Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 31, 2025
Language: Английский
Immunomodulatory Effects of Anadenanthera colubrina Bark Extract in Experimental Autoimmune Encephalomyelitis
Karla Antunes Ramos,
No information about this author
Igor Gabriel Machado Soares,
No information about this author
Larissa M. A. Oliveira
No information about this author
et al.
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(8), P. 8726 - 8740
Published: Aug. 10, 2024
This
study
aimed
to
evaluate
the
efficacy
of
ethanolic
extract
Anadenanthera
colubrina
in
modulating
immune
response
Experimental
Autoimmune
Encephalomyelitis
(EAE)
model.
The
dried
bark
was
analyzed
by
ESI
(+)
Orbitrap-MS
obtain
a
metabolite
profile,
demonstrating
wide
variety
polyphenols,
such
as
flavonoids
and
phenolic
acids.
Various
parameters
were
evaluated,
clinical
signs,
cytokines,
cellular
histopathology
central
nervous
system
(CNS).
A.
demonstrated
significant
positive
effects
attenuating
signs
pathological
processes
associated
with
EAE.
beneficial
treatment
evidenced
reduced
levels
pro-inflammatory
IL1β,
IL-6,
IL-12,
TNF,
IFN-γ,
notable
decrease
several
cell
profiles,
including
CD8+,
CD4+,
CD4+IFN-γ,
CD4+IL-17+,
CD11c+MHC-II+,
CD11+CD80+,
CD11+CD86+
CNS.
In
addition,
histological
analysis
revealed
fewer
inflammatory
infiltrates
demyelination
sites
spinal
cord
mice
treated
compared
control
model
group.
These
results
showed,
for
first
time,
that
exerts
modulatory
effect
on
processes,
improving
EAE,
acute
phase
disease,
which
could
be
further
explored
possible
therapeutic
alternative.
Language: Английский
Obesity Control and Nutraceuticals in the Aid of Brain Plasticity in Multiple Sclerosis Patients
Published: July 24, 2024
Multiple
sclerosis
(MS)
is
an
immune-mediated
disease
characterized
by
inflammation,
demyelination,
and
neurodegeneration
within
the
central
nervous
system.
Brain
plasticity,
brain's
ability
to
adapt
its
structure
function,
plays
a
crucial
role
in
mitigating
MS's
impact.
This
paper
explores
potential
benefits
of
lifestyle
changes
nutraceuticals
on
brain
plasticity
MS
patients.
Lifestyle
modifications,
including
physical
activity
dietary
adjustments,
can
enhance
upregulating
neurotrophic
factors,
promoting
synaptogenesis,
reducing
oxidative
stress.
Nutraceuticals,
such
as
vitamin
D,
omega-3
fatty
acids,
antioxidants
like
alpha-lipoic
acid,
have
shown
promise
supporting
health
through
anti-inflammatory
neuroprotective
mechanisms.
Regular
has
been
linked
increased
levels
brain-derived
factor
(BDNF)
improved
cognitive
function.
Dietary
interventions,
caloric
restriction
intake
polyphenols,
also
positively
influence
plasticity.
Integrating
these
into
management
could
provide
complementary
approach
traditional
therapies,
potentially
improving
neurological
outcomes
enhancing
quality
life
for
Language: Английский
Exploring the Therapeutic Potential: Bioactive Molecules and Dietary Interventions in Multiple Sclerosis Management
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(6), P. 5595 - 5613
Published: June 3, 2024
Multiple
sclerosis
(MS)
is
a
chronic
autoimmune
demyelinating
disease
of
the
central
nervous
system,
etiology
which
still
unclear.
Its
hallmarks
are
inflammation
and
axonal
damage.
As
primarily
impacting
younger
individuals,
social
cost
MS
high.
It
has
been
proposed
that
environmental
factors,
smoking,
dietary
habits
acting
on
genetic
susceptibility
play
role
in
MS.
Recent
studies
indicate
diet
can
significantly
influence
onset
progression
This
review
delves
into
impact
natural
bioactive
molecules
development
explores
interventions
hold
promise
managing
disease.
Dietary
patterns,
including
ketogenic
Mediterranean
diets,
discussed.
Theories
about
potential
mechanistic
associations
beneath
noted
effects
also
proposed.
Several
components
patterns
demonstrated
for
significant
However,
extensive
prospective
clinical
trials
necessary
to
fully
understand
as
modifiers
Language: Английский
Obesity Control and Supplementary Nutraceuticals as Cofactors of Brain Plasticity in Multiple Sclerosis Populations
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 10909 - 10909
Published: Oct. 10, 2024
Multiple
sclerosis
(MS)
is
an
immune-mediated
disease
characterized
by
inflammation,
demyelination,
and
neurodegeneration
within
the
central
nervous
system.
Brain
plasticity,
brain’s
ability
to
adapt
its
structure
function,
plays
a
crucial
role
in
mitigating
MS’s
impact.
This
paper
explores
potential
benefits
of
lifestyle
changes
nutraceuticals
on
brain
plasticity
MS
population.
Lifestyle
modifications,
including
physical
activity
dietary
adjustments,
can
enhance
upregulating
neurotrophic
factors,
promoting
synaptogenesis,
reducing
oxidative
stress.
Nutraceuticals,
such
as
vitamin
D,
omega-3
fatty
acids,
antioxidants
like
alpha
lipoic
acid,
have
shown
promise
supporting
health
through
anti-inflammatory
neuroprotective
mechanisms.
Regular
has
been
linked
increased
levels
brain-derived
factor
improved
cognitive
function.
Dietary
interventions,
caloric
restriction
intake
polyphenols,
also
positively
influence
plasticity.
Integrating
these
into
management
provide
complementary
approach
traditional
therapies,
potentially
improving
neurological
outcomes
enhancing
quality
life
for
Language: Английский